|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | OraPharma |
|---|---|
| Information provided by: | OraPharma |
| ClinicalTrials.gov Identifier: | NCT00371332 |
Purpose
The purpose of this study is to measure the antimicrobial effects of Arestin in subjects with moderate to advanced periodontal disease
| Condition | Intervention | Phase |
|---|---|---|
|
Periodontitis |
Drug: Minocycline HCL Microspheres |
Phase III |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
| Estimated Enrollment: | 128 |
| Study Start Date: | January 2004 |
Eligibility| Ages Eligible for Study: | 30 Years to 65 Years |
| Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, California | |
| Los Angeles, California, United States | |
| United States, Maryland | |
| Baltimore, Maryland, United States | |
| United States, Massachusetts | |
| Boston, Massachusetts, United States | |
| United States, New York | |
| Buffalo, New York, United States | |
| United States, Tennessee | |
| Memphis, Tennessee, United States | |
More Information
| Study ID Numbers: | OPI-145` |
| Study First Received: | September 1, 2006 |
| Last Updated: | September 22, 2006 |
| ClinicalTrials.gov Identifier: | NCT00371332 History of Changes |
| Health Authority: | United States: Food and Drug Administration |
|
chronic periodontitis, mouth Moderate to advanced chronic periodontitis |
|
Mouth Diseases Anti-Infective Agents Anti-Bacterial Agents Minocycline Periodontal Diseases |
Periodontitis Therapeutic Uses Stomatognathic Diseases Pharmacologic Actions |